Suppr超能文献

一项比较未破裂颅内动脉瘤的手术夹闭与血管内治疗的实用随机试验。

A Pragmatic Randomized Trial Comparing Surgical Clipping and Endovascular Treatment of Unruptured Intracranial Aneurysms.

机构信息

From the Division of Neurosurgery (T.E.D., J.M.F., M.B.K., M.M.C.C., C.J.O.).

Service of Neurosurgery (M.W.B., C.C.).

出版信息

AJNR Am J Neuroradiol. 2023 Jun;44(6):634-640. doi: 10.3174/ajnr.A7865. Epub 2023 May 11.

Abstract

BACKGROUND AND PURPOSE

Surgical clipping and endovascular treatment are commonly used in patients with unruptured intracranial aneurysms. We compared the safety and efficacy of the 2 treatments in a randomized trial.

MATERIALS AND METHODS

Clipping or endovascular treatments were randomly allocated to patients with one or more 3- to 25-mm unruptured intracranial aneurysms judged treatable both ways by participating physicians. The study hypothesized that clipping would decrease the incidence of treatment failure from 13% to 4%, a composite primary outcome defined as failure of aneurysm occlusion, intracranial hemorrhage during follow-up, or residual aneurysms at 1 year, as adjudicated by a core lab. Safety outcomes included new neurologic deficits following treatment, hospitalization of >5 days, and overall morbidity and mortality (mRS > 2) at 1 year. There was no blinding.

RESULTS

Two hundred ninety-one patients were enrolled from 2010 to 2020 in 7 centers. The 1-year primary outcome, ascertainable in 290/291 (99%) patients, was reached in 13/142 (9%; 95% CI, 5%-15%) patients allocated to surgery and in 28/148 (19%; 95% CI, 13%-26%) patients allocated to endovascular treatments (relative risk: 2.07; 95% CI, 1.12-3.83; = .021). Morbidity and mortality (mRS >2) at 1 year occurred in 3/143 and 3/148 (2%; 95% CI, 1%-6%) patients allocated to surgery and endovascular treatments, respectively. Neurologic deficits (32/143, 22%; 95% CI, 16%-30% versus 19/148, 12%; 95% CI, 8%-19%; relative risk: 1.74; 95% CI, 1.04-2.92; = .04) and hospitalizations beyond 5 days (69/143, 48%; 95% CI, 40%-56% versus 12/148, 8%; 95% CI, 5%-14%; relative risk: 0.18; 95% CI, 0.11-0.31; < .001) were more frequent after surgery.

CONCLUSIONS

Surgical clipping is more effective than endovascular treatment of unruptured intracranial aneurysms in terms of the frequency of the primary outcome of treatment failure. Results were mainly driven by angiographic results at 1 year.

摘要

背景与目的

手术夹闭和血管内治疗常用于颅内未破裂动脉瘤患者。我们在一项随机试验中比较了这两种治疗方法的安全性和有效性。

材料和方法

夹闭或血管内治疗随机分配给通过参与医生判断为可通过这两种方法治疗的 1 个或多个 3-25mm 的颅内未破裂动脉瘤的患者。该研究假设夹闭将使治疗失败的发生率从 13%降至 4%,主要复合终点定义为动脉瘤闭塞失败、随访期间颅内出血或 1 年后仍存在动脉瘤,由核心实验室裁决。安全性结局包括治疗后新出现的神经功能缺损、住院时间>5 天以及 1 年时的总体发病率和死亡率(mRS>2)。无盲法。

结果

2010 年至 2020 年在 7 个中心共纳入 291 例患者。291 例患者中的 290 例(99%)可评估 1 年的主要结局,手术组 13 例(9%;95%CI,5%-15%)和血管内治疗组 28 例(19%;95%CI,13%-26%)达到该主要结局(相对风险:2.07;95%CI,1.12-3.83; =.021)。手术组和血管内治疗组 1 年时的发病率和死亡率(mRS>2)分别为 3/143(2%;95%CI,1%-6%)和 3/148(2%;95%CI,1%-6%)。神经功能缺损(32/143,22%;95%CI,16%-30% 与 19/148,12%;95%CI,8%-19%;相对风险:1.74;95%CI,1.04-2.92; =.04)和住院时间>5 天(69/143,48%;95%CI,40%-56% 与 12/148,8%;95%CI,5%-14%;相对风险:0.18;95%CI,0.11-0.31;<0.001)在手术后更为常见。

结论

就治疗失败的主要结局发生率而言,手术夹闭治疗颅内未破裂动脉瘤比血管内治疗更有效。结果主要由 1 年时的血管造影结果驱动。

相似文献

6
The Barrow Ruptured Aneurysm Trial: 6-year results.巴罗破裂动脉瘤试验:6年结果。
J Neurosurg. 2015 Sep;123(3):609-17. doi: 10.3171/2014.9.JNS141749. Epub 2015 Jun 26.

引用本文的文献

9
Intracranial aneurysm coexisting with pituitary adenoma: a systematic review.颅内动脉瘤与垂体腺瘤共存:一项系统综述。
Ann Med Surg (Lond). 2024 Oct 25;86(12):7232-7237. doi: 10.1097/MS9.0000000000002692. eCollection 2024 Dec.

本文引用的文献

6
Treatments for unruptured intracranial aneurysms.未破裂颅内动脉瘤的治疗方法。
Cochrane Database Syst Rev. 2021 May 10;5(5):CD013312. doi: 10.1002/14651858.CD013312.pub2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验